Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9701758 Anti-CD19 scFv (FMC63) polypeptide

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
May 23, 2014
Date of Patent
July 11, 2017
Patent Application Number
14893223
Patent Citations Received
‌
US Patent 12115191 Methods of treating age-related and inflammatory diseases
0
‌
US Patent 12018071 Single-chain chimeric polypeptides and uses thereof
0
‌
US Patent 12024545 Methods of treating aging-related disorders
0
‌
US Patent 12090171 Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same and use thereof
0
‌
US Patent 11672826 Methods of treating aging-related disorders
0
‌
US Patent 11759480 Compositions and methods for CAR T cell therapy
‌
US Patent 11779602 Methods of use for CAR T cells
‌
US Patent 11850262 Compositions and methods for CAR T cell therapy
0
‌
US Patent 11884712 Multi-chain chimeric polypeptides and uses thereof
0
‌
US Patent 11987619 Single-chain chimeric polypeptides and uses thereof
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9701758
Patent Primary Examiner
‌
Phillip Gambel

Find more entities like US Patent 9701758 Anti-CD19 scFv (FMC63) polypeptide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.